176 results
8-K
EX-99.1
NAVB
Navidea Biopharmaceuticals, Inc.
16 Jun 23
Navidea Biopharmaceuticals, Inc. Receives $7.5 Million Cash from Cardinal Health in Lieu of Contingent Milestone Payment
5:24pm
of pharmaceuticals, a global manufacturer and distributor of medical and laboratory products, and a provider of performance and data solutions for healthcare
424B5
NAVB
Navidea Biopharmaceuticals, Inc.
28 Apr 23
Prospectus supplement for primary offering
10:55am
partners, as well as the effects on worldwide economies, financial markets, social institutions, labor markets and healthcare systems.
The current … and healthcare systems;
the impact of the current conflict between Ukraine and Russia on our business, financial condition or prospects, including
424B4
b793xwe8sr c7b81e33
4 Aug 22
Prospectus supplement with pricing info
1:03pm
8-K
EX-99.1
7lkx4 4v2qz2ay1fli9
14 Oct 21
Navidea Biopharmaceuticals Appoints Thomas Forest Farb-Horch and Agnieszka Winkler to the Board of Directors
4:01pm
424B3
zd3o5z42 ik9ef1d4l
24 May 21
Prospectus supplement
4:02pm